Benefit-harm balance of fingolimod in patients with MS: a modelling study based on FREEDOMS

Publication date: Available online 23 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Alessandra Spanu, Hélène E. Aschmann, Jürg Kesselring, Milo A. Puhan

Source: Multiple Sclerosis and Related Disorders - August 23, 2020 Category: Neurology Source Type: research